OM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Outset Medical Inc

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
CEO
Employees
313
Headquarters

News

NASDAQ: OM Investor Alert: Lawsuit Alleges Misleading Statements by Outset Medical, Inc.
Aug 16, 2022 15:38pm

A lawsuit was filed on behalf of investors in Outset Medical, Inc. (NASDAQ: OM) shares over alleged securities laws violations. San Diego, CA -- ( SBWIRE ) -- 08/16/2022 -- An investor, who purchased shares of Outset Medical, Inc. (NASDAQ: OM), filed a lawsuit over alleged Securities Laws violations by Outset Medical, Inc.. Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 6, 2022. NASDAQ: OM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Jose, CA based Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. On June 13, 2022, Outset Medical, Inc. announced that "it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the Food and Drug Administration''s (FDA) review and clearance of a 510(k) the company submitted for changes made since the device''s original March 2020 clearance." Shares of Outset Medical, Inc. (NASDAQ: OM) declined from $40.51 per share on May 4, 2022, to as low as $13.25 per share on June 14, 2022.


Source:SBWire
OM stock gains on VA contract for hemodialysis (NASDAQ:OM)
Aug 15, 2022 16:47pm

MedTech company Outset Medical (OM) announced on Monday that it won a national contract from the Department of Veterans Affairs to supply its Tablo Hemodialysis System for 106 VA…


Source:Seeking Alpha
OM LAWSUIT ALERT: Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Aug 11, 2022 09:45am


Source:Kwhen Finance
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm''s Attorneys, Securities Fraud Class Action Pending
Aug 09, 2022 18:25pm

SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM ) investors who have suffered over $300,000 losses to submit your losses now . Class Period: Sept. 15, 2020 – June 13, 2022 Lead Plaintiff Deadline: Sept. 6, 2022 Visit: www.hbsslaw.com/investor-fraud/OM Contact An Attorney Now: OM@hbsslaw.com 844-916-0895 Outset Medical, Inc. (NASDAQ: OM ) Securities Fraud Class Action: The complaint challenges Outset''s claims concerning its flagship product, Tablo, including that it can "serve as a dialysis clinic on wheels" and that it had been cleared by the FDA for use in hospitals, clinics, and home settings under Section 510(k) of the Federal Food Drug and Cosmetics Act. The complaint also focuses on Outset''s statements … Full story available on Benzinga.com


Source:Benzinga
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Pending
Aug 09, 2022 18:25pm

SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who have suffered over $300,000 losses to submit your losses now .


Source:GlobeNewswire
Outset Medical, Inc. (OM) CEO Leslie Trigg on Q2 2022 Results - Earnings Call Transcript
Aug 05, 2022 19:51pm

Outset Medical, Inc. (NASDAQ:NASDAQ:OM) Q2 2022 Earnings Conference Call August 01, 2022 05:00 PM ET Company Participants Jim Mazzola - Vice President Investor Relations Leslie Trigg -…


Source:Seeking Alpha
Pearson, Nikola And Some Other Big Gainers From Monday
Aug 02, 2022 10:00am

U.S. stocks closed slightly lower on Monday, with the Nasdaq Composite dropping around 02%. Here is the list of some big stocks moving higher in the previous session. Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB ) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday. AMTD Digital Inc. (NYSE: HKD ) rose 85.4% to settle at $742.00 on continued upward volatility following the stock''s July IPO. Outset Medical, Inc. (NASDAQ: OM ) gained 26.9% to close at $19.61 after the company announced the resumption of Tablo Hemodialysis System shipments for home use. EVO Payments, Inc. (NASDAQ: EVOP ) gained 23.3% to close at $33.71 after Global Payments entered an agreement to acquire the company for $34 per share in cash. ToughBuilt Industries, Inc. (NASDAQ: TBLT ) rose 21.9% to settle at $8.64 after the company announced it has started to sell 93 of its products on Amazon Italy and Amazon Germany. Getty Images Holdings, Inc. (NYSE: GETY ) jumped 18.9% to close at $31.10.


Source:Benzinga
Outset Medical Shares Jump On Resuming Tablo Hemodialysis For Home Use
Aug 01, 2022 15:14pm

The FDA cleared Outset Medical Inc''s (NASDAQ: OM ) previously disclosed 510(k) submission and resumption of Tablo Hemodialysis System shipments for home use. Stifel noted that the decision means that "the new device is as safe and effective as the predicate. In June, Outset Medical implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the FDA review and clearance of a 510(k). As Stifel awaits further information from management on the decision, next steps, and ship hold removal, the analyst still view this as highly encouraging for Outset. A "substantially-equivalent" designation by … Full story available on Benzinga.com


Source:Benzinga
OM stock jumps after 2Q results as FDA clears hemodialysis system (NASDAQ:OM)
Aug 01, 2022 14:55pm

Outset Medical (OM) added ~24% in the morning hours Monday after the MedTech company announced the FDA clearance of Tablo Hemodialysis System with its 2Q 2022 results.With the clearance…


Source:Seeking Alpha
Cowen Reiterates Outperform Rating on Outset Medical Inc. , Comments on FDA Clearance
Aug 01, 2022 13:10pm

https://www.investing.com/news/pro/cowen-reiterates-outperform-rating-on-outset-medical-inc--comments-on-fda-clearance-432SI-2859425


Source:Investing.com
Stifel on Outset Medical Inc. : ''At Last, A Big Sigh of Relief As FDA Terms Tablo Catch-Up Filing As “Substantially-Equivalent”''
Aug 01, 2022 13:09pm

https://www.investing.com/news/pro/stifel-on-outset-medical-inc--at-last-a-big-sigh-of-relief-as-fda-terms-tablo-catchup-filing-as-substantiallyequivalent-432SI-2859424


Source:Investing.com
Outset Medical, Inc. Investigation: Robbins LLP Is Investigating Outset Medical, Inc. (OM) on Behalf of Shareholders
Jul 28, 2022 19:16pm

Robbins LLP is investigating Outset Medical, Inc. to determine whether it violated securities laws in connection with its Tablo Hemodialysis System.


Source:Business Wire
OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit
Jul 27, 2022 16:00pm

LOS ANGELES, July 27, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. ("Outset" or the "Company") (NASDAQ: OM). Class Period: September…


Source:PR Newswire
OUTSET MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Outset Medical, Inc. - OM
Jul 23, 2022 02:50am


Source:Kwhen Finance
Outset Medical, Inc. Shareholder Update: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Outset Medical, Inc. (OM)
Jul 22, 2022 23:50pm

SAN DIEGO, July 22, 2022 (GLOBE NEWSWIRE) -- The Class : Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased Outset Medical, Inc. (NASDAQ: OM) common stock between September 15, 2020 and June 13, 2022, for violations of the Securities Exchange Act of 1934. Outset Medical is a medical technology company focused on kidney dialysis, the primary treatment for acute and chronic kidney failure. The Company''s flagship product is the Tablo Hemodialysis System.


Source:GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wells Fargo, Unity, Amazon, and Outset Medical and Encourages Investors to Contact the Firm
Jul 21, 2022 01:00am

NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Wells Fargo & Company (NYSE: WFC), Unity Software, Inc. (NYSE: U), Amazon.com, Inc. (NASDAQ: AMZN), and Outset Medical, Inc. (NASDAQ: OM). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.


Source:GlobeNewswire
OUTSET MEDICAL, INC. (NASDAQ: OM) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Outset Medical, Inc. (NASDAQ: OM)
Jul 19, 2022 16:30pm

Did you lose money on investments in Outset Medical? If so, please visit Outset Medical, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.


Source:GlobeNewswire
OM ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 6, 2022 in the Class Action Filed on Behalf of Outset Medical, Inc. Shareholders
Jul 19, 2022 09:45am

NEW YORK, July 19, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) alleging that the Company violated federal securities laws. This lawsuit is on behalf of all persons or entities…


Source:PR Newswire
OM INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Outset Medical (OM) Investors Who Suffered Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Class Action Filed
Jul 18, 2022 17:58pm

SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who have suffered over $300,000 losses to submit your losses now .


Source:GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outset Medical, Inc. (OM)
Jul 18, 2022 15:00pm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 6, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) common stock between September 15, 2020 and June 13, 2022, inclusive (the “Class Period”). If you suffered a loss on your Outset investments or would like to inquire about potentially pursu


Source:Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Unity Software, Outset Medical, Missfresh, and Molecular Partners and Encourages Investors to Contact the Firm
Jul 16, 2022 01:00am

NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Unity Software, Inc. (NYSE: U), Outset Medical, Inc. (NASDAQ: OM), Missfresh Limited (NASDAQ: MF), and Molecular Partners AG (NASDAQ: MOLN). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.


Source:GlobeNewswire
Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Outset Medical, Inc. (OM)
Jul 15, 2022 23:17pm

SAN DIEGO--(BUSINESS WIRE)---- $OM #OM--Outset Medical, Inc. (OM) Misled Investors Regarding Tablo''s Use and FDA Approval


Source:Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Outset Medical, Inc. (OM) Investors of Class Action and Encourages Investors to Contact the Firm
Jul 15, 2022 15:00pm

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ: OM) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Outset securities between September 15, 2020, and June 13, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:


Source:Business Wire
OM LAWSUIT ALERT: Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Jul 14, 2022 09:45am

NEW YORK, July 14, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Outset Medical investors who…


Source:PR Newswire
The Law Offices of Timothy L. Miles Reminds Investors of a Class Action Lawsuit Against Outset Medical, Inc. (OM)
Jul 14, 2022 06:39am

Class action lawsuit charges Outset Medical and certain of its top executive officers with violations of the Securities Exchange Act of 1934. NASHVILLE, TENNESSEE, UNITED STATES, July 14, 2022 /⁨EINPresswire.com⁩/ -- The Law Offices of Timothy L. …


Source:EIN News Bitcoin
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Outset Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 6, 2022 - (NASDAQ: OM)
Jul 13, 2022 09:45am

NEW YORK, July 13, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Outset Medical, Inc.. Shareholders who purchased shares of OM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….


Source:PR Newswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc. (OM) Investors
Jul 12, 2022 17:00pm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) common stock between September 15, 2020 and June 13, 2022, inclusive (the “Class Period”). Outset investors have until September 6, 2022 to file a lead plaintiff motion. If you suffered a loss on your Outse


Source:Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc. (OM) Investors
Jul 12, 2022 15:45pm

LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc. (OM) Investors


Source:Business Wire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors Who Suffered Over $300,000 Losses to Contact the Firm''s Attorneys, Securities Fraud Class Action Filed
Jul 12, 2022 00:54am

SAN FRANCISCO, July 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM ) investors who have suffered over $300,000 losses to submit your losses now . Class Period: Sept. 15, 2020 – June 13, 2022 Lead Plaintiff Deadline: Sept. 6, 2022 Visit: www.hbsslaw.com/investor-fraud/OM Contact An Attorney Now: OM@hbsslaw.com 844-916-0895 Outset Medical, Inc. (NASDAQ: OM ) Securities Fraud Class Action: The complaint challenges Outset''s claims concerning its flagship product, Tablo, including that it can "serve as a dialysis clinic on wheels" and that it had been cleared by the FDA for use in hospitals, clinics, and home settings under Section 510(k) of the Federal Food Drug and Cosmetics Act. The complaint also focuses on Outset''s statements that, when conducting additional regulatory studies pertaining … Full story available on Benzinga.com


Source:Benzinga
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors Who Suffered Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed
Jul 12, 2022 00:54am

SAN FRANCISCO, July 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who have suffered over $300,000 losses to submit your losses now .


Source:GlobeNewswire
SHAREHOLDER ACTON REMINDER: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $100,000 to Contact the Firm
Jul 11, 2022 14:17pm

LOS ANGELES--(BUSINESS WIRE)---- $OM #OM--The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $100,000 to Contact the Firm


Source:Business Wire
SHAREHOLDER ACTON ALERT: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $500,000 to Contact the Firm
Jul 10, 2022 18:24pm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. (“Outset” or “the Company”) (NASDAQ: OM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company''s securities


Source:Wallstreet:Online
OM Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their Outset Medical Losses
Jul 09, 2022 17:53pm

SAN DIEGO, July 09, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Outset Medical, Inc. (“Outset Medical” or the “Company”) ( NASDAQ: OM ). The class action is on behalf of shareholders who purchased Outset Medical securities between September 15, 2020 and June 13, 2022, both dates inclusive (the “Class Period). Investors are hereby notified that they have until September 6, 2022 to move the Court to serve as lead plaintiff in this action.


Source:GlobeNewswire
Saxena White P.A. Files New Securities Fraud Class Action Against Outset Medical, Inc.
Jul 08, 2022 22:17pm

BOCA RATON, Fla., July 08, 2022 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit (the "Class Action") in the United States District Court for the Northern District of California against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM ) and certain of its executive officers (collectively, "Defendants"). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder on behalf of all persons or entities that purchased Outset Medical common stock between September 15, 2020 and June 13, 2022, inclusive (the "Class Period"), and were damaged thereby (the "Class"). The Class Action filed by Saxena White is captioned: Plymouth County Retirement Association v. Outset Medical, Inc. , No. 5:22-cv-04016 (N.D. Cal.) Outset Medical is a medical technology company focused on kidney dialysis, the primary treatment for acute and chronic kidney failure.


Source:Benzinga
Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, Allianz, Outset Medical, and TrueBlue and Encourages Investors to Contact the Firm
Jul 05, 2022 01:00am

NEW YORK, July 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc. (NASDAQ: TGTX), Allianz SE (OTCMKTS: ALIZY), Outset Medical, Inc. (NASDAQ: OM), and TrueBlue, Inc. (NYSE: TBI). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.


Source:GlobeNewswire
NASDAQ:OM Investor Notice: Investigation Concerning Potential Violations of Securities Laws by Outset Medical, Inc.
Jul 01, 2022 17:15pm

An investigation for investors in Outset Medical, Inc. (NASDAQ:OM) shares over potential securities laws violations by Outset Medical, Inc. was announced. San Diego, CA -- ( SBWIRE ) -- 07/01/2022 -- An investigation on was announced over potential securities laws violations by Outset Medical, Inc. in connection with certain financial statements. Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series of statements by Outset Medical, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made. San Jose, CA based Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. Outset Medical, Inc. reported that its annual Total Revenue rose from $49.93 million in 2020, to $102.6 million in 2021, and that its Net Loss increased from $121.49 million in 2020, to $131.93 million in 2021.


Source:SBWire
Bragar Eagel & Squire, P.C. Is Investigating Outset Medical, TrueBlue, Gap, and NeoGenomics and Encourages Investors to Contact the Firm
Jun 25, 2022 01:00am

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ: OM), TrueBlue, Inc. (NYSE: TBI), Gap, Inc. (NYSE: GPS), and NeoGenomics, Inc. (NASDAQ: NEO). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.


Source:GlobeNewswire
Outset Medical Inc. (NASDAQ: OM) Up 0.63%: This Is What Analysts Now Expect
Jun 23, 2022 15:30pm

Outset Medical Inc. (NASDAQ:OM) shares, rose in value on Wednesday, 06/22/22, with the stock price up by 0.63% to the previous day’s close as strong demand from buyers drove the stock to $14.41. Actively observing the price movement in the last trading, the stock closed the session at $14.32, falling within a range of $14.05 … Outset Medical Inc. (NASDAQ: OM) Up 0.63%: This Is What Analysts Now Expect Read More »


Source:Stocks Register